Literature DB >> 24535633

Diastematomyelia in congenital scoliosis: a report of two cases.

Stefan Gavriliu1, Costel Vlad, Ileana Georgescu, Gheorghe Burnei.   

Abstract

INTRODUCTION: Even if diastematomyelia is a rare condition, it always has to be identified in case of diagnosing and treating a case of congenital scoliosis. The consequence of missing the diagnosis of such a malformation may be devastating to the involved patient. This paper wants once again to make aware the physicians of the eventual presence of a spinal dysraphic malformation when dealing with a congenital spinal malformation.
METHODS: The presence of diastematomyelia was noticed in two of our cases, one with congenital scoliosis and another with congenital kyphoscoliosis. First of all in these cases, we performed the resection of the bony septum, followed by spinal fusion in a single-stage surgical procedure. We noticed no complications during and after surgery related to the resection of the bony septum.
RESULTS: In both patients, we obtained partial correction and stabilization of the congenital spinal malformation after a safe excision of the bony septum.
CONCLUSIONS: Diastematomyelia is a rare condition. It has to be taken into consideration when dealing with a congenital scoliosis. The first step in the surgical procedure has to be the resection of the diastematomyelic septum. In case of a scoliosis ranging up to 30° and not presenting a progressive potential, the expectative-evaluation attitude is a correct one.

Entities:  

Mesh:

Year:  2014        PMID: 24535633     DOI: 10.1007/s00586-014-3218-x

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  10 in total

Review 1.  Neural tube defects.

Authors:  Bruce A Kaufman
Journal:  Pediatr Clin North Am       Date:  2004-04       Impact factor: 3.278

2.  Lumbar hemivertebra resection by posterior approach for congenital scoliosis.

Authors:  Ibrahim Obeid; Anouar Bourghli; Jean-Marc Vital
Journal:  Eur Spine J       Date:  2012-12       Impact factor: 3.134

3.  Thoracic hemivertebra resection by posterior approach for congenital scoliosis.

Authors:  Ibrahim Obeid; Anouar Bourghli; Jean-Marc Vital
Journal:  Eur Spine J       Date:  2013-03       Impact factor: 3.134

Review 4.  Occult tethered cord syndrome: a review.

Authors:  Albert Tu; Paul Steinbok
Journal:  Childs Nerv Syst       Date:  2013-09-07       Impact factor: 1.475

5.  Diastematomyelia--the "double-barrelled" spine.

Authors:  J G Edelson; H Nathan; B Arensburg
Journal:  J Bone Joint Surg Br       Date:  1987-03

6.  Thoracic myelopathy caused by cervicothoracic diastematomyelia. A case report.

Authors:  T Ohwada; K Okada; H Hayashi
Journal:  J Bone Joint Surg Am       Date:  1989-02       Impact factor: 5.284

7.  The efficacy and complications of posterior hemivertebra resection.

Authors:  Jianguo Zhang; Wang Shengru; Guixing Qiu; Bin Yu; Wang Yipeng; Keith D K Luk
Journal:  Eur Spine J       Date:  2011-02-12       Impact factor: 3.134

8.  Evaluation and treatment of diastematomyelia.

Authors:  A Miller; J T Guille; J R Bowen
Journal:  J Bone Joint Surg Am       Date:  1993-09       Impact factor: 5.284

Review 9.  Split cord malformation: Part I: A unified theory of embryogenesis for double spinal cord malformations.

Authors:  D Pang; M S Dias; M Ahab-Barmada
Journal:  Neurosurgery       Date:  1992-09       Impact factor: 4.654

Review 10.  Congenital scoliosis.

Authors:  V Arlet; Th Odent; M Aebi
Journal:  Eur Spine J       Date:  2003-06-14       Impact factor: 3.134

  10 in total
  2 in total

1.  Congenital scoliosis: an up-to-date.

Authors:  G Burnei; S Gavriliu; C Vlad; I Georgescu; R A Ghita; C Dughilă; E M Japie; A Onilă
Journal:  J Med Life       Date:  2015 Jul-Sep

2.  Excision and short segment fusion of a double ipsilateral lumbar hemivertebrae associated with a diastematomyelia and fixed pelvic obliquity.

Authors:  Alpaslan Senkoylu; Mehmet Cetinkaya; Erdem Aktas; Engin Cetin
Journal:  Acta Orthop Traumatol Turc       Date:  2019-02-02       Impact factor: 1.511

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.